EVALUATION OF TREATMENT OUTCOMES OF EXTERNAL VENTRICULAR DRAINAGE IN PATIENTS WITH INTRAVENTRICULAR HEMORRHAGE
Main Article Content
Abstract
Objective: To evaluate the treatment outcomes of patients with intracerebral hemorrhage and acute intraventricular hemorrhage (IVH) using external ventricular drainage (EVD) and to analyze some related factors. Subjects: A total of 66 patients with intracerebral hemorrhage who met the criteria for emergency intervention and were treated at the Stroke Department of 108 Military Central Hospital from January 2022 to April 2024. Methods: Interventional, prospective, longitudinal follow-up study without control groups. Results: Six months after discharge, 22.7% of the patients achieved good recovery outcomes (mRS 0–3). The main complications included pneumonia (36.4%) and chronic ventricular dilation (43.9%). The recurrence rate of intracerebral hemorrhage was 3%, and no patients who received intraventricular fibrinolysis experienced recurrent bleeding. Preoperative Glasgow Coma Scale (GCS) and NIHSS scores showed statistically significant differences between the groups with mRS scores of 0–3 and 4–6 after 6 months (p < 0.05). Specifically, a GCS score ≤ 8 and NIHSS score ≥ 22 were predictive of poor prognosis (mRS 4–6) after 6 months. Other factors, such as Graeb score, ICH score, IVH score, and hematoma volume, did not show significant differences between the two groups.
Conclusion: Patients with intracerebral hemorrhage and acute ventricular dilation have poor recovery prognoses, posing significant burdens on both the patients and their families. External ventricular drainage, with or without intraventricular fibrinolysis, is an effective method to improve outcomes for these patients.
Keywords: Intracerebral hemorrhage with intraventricular hemorrhage, external ventricular drainage, prognostic factors.
Article Details
Keywords
Chảy máu não tràn máu não thất, Dẫn lưu não thất mở, Yếu tố tiên lượng
References
2. Hanley DF, Lane K, McBee N, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: Results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. Feb 11 2017; 389(10069):603-611.
3. De Oliveira Manoel AL. Surgery for spontaneous intracerebral hemorrhage. Crit Care. Feb 7 2020; 24(1):45. DOI:10.1186/s13054-020-2749-2.
4. Walek KW, Leary OP, Sastry R, et al. Risk factors and outcomes associated with external ventricular drain infections. Infect Control Hosp Epidemiol. Dec 2022; 43(12):1859-1866.
5. Nguyễn Thị Cúc. Nhận xét 10 trường hợp chảy máu não thất điều trị bằng dẫn lưu não thất ngoài kết hợp bơm alteplase qua dẫn lưu. Tạp chí Y học Việt Nam. 9/2019; 482:255-263.
8. Castano Avila S, Corral Lozano E, Vallejo De La Cueva A, et al. Intraventricular hemorrhage treated with intraventricular fibrinolysis. A 10-year experience. Med Intensiva. Mar 2013; 37(2):61-66. DOI:10.1016/j.medin.2012. 02.011
9. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: A systematic review. Stroke. Aug 2003; 34(8):2060-2065.
10. Nishikawa T, Ueba T, Kajiwara M, Miyamatsu N, Yamashita K. A priority treatment of the intraventricular hemorrhage (IVH) should be performed in the patients suffering intracerebral hemorrhage with large IVH. Clin Neurol Neurosurg. Jun 2009; 111(5):450-453.
11. Lương Quốc Chính. Nghiên cứu hiệu quả kết hợp dẫn lưu và sử dụng Alteplase não thất trong điều trị chảy máu não thất, Luận văn tiến sỹ y học, Trường Đại học Y Hà Nội, Hà Nội. 2017.